-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on MetLife, Lowers Price Target to $94

Benzinga·04/10/2025 16:29:58
Listen to the news
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and lowers the price target from $109 to $94.